Effect of Sitagliptin on Polycystic Ovarian Syndrome Patients
NCT05972928
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Polycystic Ovary Syndrome
Interventions
DRUG:
Sitagliptin 100mg
Sponsor
Beni-Suef University